Celgene to pay $1 billion for biotech collaboration with Juno
• https://www.bostonglobe.com, By Andrew PollackCelgene, a leading biotech company, said Monday that it would pay about $1 billion to start a collaboration with Juno Therapeutics, a leader in the hot new area of cancer drugs that harness patients' immune systems to attack tumors.
